Sweden
-
Thermo Fisher Adds Proteomics to Its Portfolio Through $3.1B Olink Acquisition
Thermo Fisher Scientific is acquiring Olink, a company that provides proteomics analysis tools and services used in drug discovery research. Olink’s growing revenue will help shore up a Thermo Fisher business segment whose sales have fallen due to declining Covid-19 testing demand.
-
Devices & Diagnostics, Health Tech, Startups
Swedish Startup Snags $65M for Scanning Tech Designed to Facilitate Earlier Disease Detection
Neko Health recently raised €60 million (about $65.8 million) in Series A financing. The Stockholm-based startup’s medical scanning technology aims to conveniently and affordably collect extensive health data to aid doctors in catching diseases early. The company’s scan takes about 10 minutes and costs €250 (about $275).
-
Jorie Healthcare CEO Shares Why Automation is Critical to Revenue Cycle Management
The revenue cycle management business is using AI tools to automate cumbersome tasks to help hospitals operate more efficiently. It’s beginning to attract the attention of major healthcare organizations.
-
Sobi and Selecta Bio Gout Drug Hits Phase 3 Goals, Paving Way for FDA Submission
Sobi said it plans to seek FDA approval of the gout drug, SEL-212, in 2024. If approved, it would compete against Krystexxa, a Horizon Therapeutics drug projected to become a blockbuster seller.
-
Study finds promise in digital programs for treating knee pain
A randomized, controlled study published in JAMA Open found that patients who engaged in a virtual physical therapy program saw a greater reduction in knee pain than those who continued with their usual care plan at home. However, the study was not blinded, which could affect patients’ self-reported pain scores.
-
US, UK researchers win Nobel Prize for medicine for research on cells’ adaption to oxygen availability
The Nobel Prize in Medicine or Physiology went to Drs. William Kaelin, Gregg Semenza and Peter Ratcliffe. Their research has led to new strategies for treating diseases like cancers and anemia.
-
Sanofi’s billion-dollar multiple sclerosis drug faces competitive threat from Novartis, J&J agents
On Friday, Novartis presented data at ECTRIMS showing that Arzerra had superior efficacy to Sanofi’s Aubagio. Johnson & Johnson’s Janssen division had presented data for its drug, ponesimod, two days before.
-
Oncopeptides looks forward to updates on myeloma drug at European hematology conference
In a phone interview, CEO Jakob Lindberg indicated that data so far showed a study was doing well in terms of progression-free survival.
-
FDA approves Sobi’s Gamifant for rare immune disease
The Swedish drugmaker acquired rights to the drug from Switzerland-based Novimmune in July for about $50 million, plus about $400 million in payments over eight years.
-
AstraZeneca sells US rights to RSV drug to Swedish firm for $1.5B
Sobi buys US rights to Synagis, currently the only drug approved for treating RSV, along with 50 percent of US earnings for its successor, the Phase II MEDI8897.
-
Navigating Healthcare’s Data Revolution: Priorities, Opportunities, and Challenges for Health Systems
Arcadia recently partnered with HIMSS Market Insights to survey executives, IT, technology, and clinical leaders. Here’s what we found.
-
Elekta bets MRI is the next step in radiotherapy
The challenge with radiation and other cancer therapies is getting the right amount of treatment to the tumor and leaving healthy cells unscathed.
-
Arthro Therapeutics raises $2.2M to support digital arthritis care
The company will use most of the new funding to build up its sales, business development and marketing operations, with the goal of fully entering the U.S. market by the second quarter of 2017.
-
Press Ganey being privatized in $2.35 billion deal (updated)
The deal will privatize South Bend, Indiana-based Press Ganey just 16 months after it had gone public.
-
Swedish design firm Pond Healthcare collaborates with Novartis on smart spirometer
Pond Healthcare Innovation CEO Daniel Taub said in an interview that the Air Smart spirometer device is CE-certified by European regulators and is available in Europe
-
Orphan drug developer Infant Bacterial Therapeutics gets $4.1 million
Clinical trials are three years away for this necrotising enterocolitis treatment.
-
Blood donors in Sweden receive a text message when their blood is used
With blood donation rates continuing to decrease, initiatives to make the process more personal and social could make a big difference.